Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea-Reference-Cited by-同舟云学术

Real‐world data for the use of emicizumab in haemophilia A patients with inhibitors – First nationwide report from Korea

Author:

Hahn Seung Min¹²^ORCID,Han Jung Woo¹²,Kim Jin Seok³^ORCID,Shim Ye Jee⁴,Kim Soyon⁵,Kim Hugh Chul⁵,Park Young Shil⁶^ORCID,Lyu Chuhl Joo¹²

Affiliation:

1. Department of Pediatrics Yonsei University College of Medicine Seoul South Korea

2. Department of Pediatric Hematology‐Oncology Yonsei Cancer Center Severance Hospital Yonsei University College of Medicine Seoul South Korea

3. Department of Internal Medicine Yonsei University College of Medicine Seoul South Korea

4. Department of Pediatrics Keimyung University School of Medicine Keimyung University Dongsan Hospital Daegu South Korea

5. Kim & Lee's Internal Medicine Clinic Seoul South Korea

6. Department of Pediatrics Kyung Hee University College of Medicine Kyung Hee University Hospital at Gangdong Seoul South Korea

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

Reference10 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献